Halladay Benjamin 4
4 · Esperion Therapeutics, Inc. · Filed Jul 18, 2025
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-07-17$1.11/sh−11$12→ 474,462 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.